Doctor profile · Federal record
Dr. Mary Clare Bohnett, MD
Dermatology Physician (CMS: Dermatology) · Clackamas, OR
- NPI 1710482013
- Accepts Medicare
- MIPS 87.8 / 100 · 2023
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
10151 Se Sunnyside RD Ste 240
Clackamas, OR 970155774
(503) 962-1840 - Additional location
-
1411 E 31St St Fl 2
Oakland, CA 946021018
(510) 437-5039 - Mailing address
-
Po Box 3158
Portland, OR 972083158
Credentials & registration
- NPI registered
- March 2018 — 8 yrs on file
- Profile last updated
- December 2, 2022
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Oregon #MD210673
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1710482013. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,164
Distinct HCPCS
10
Medicare allowed
$81,017
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 280 | 72 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 195 | 155 | $92 | |
17000 |
Destruction of precancer skin growth, 1 growth | 143 | 118 | $51 | |
17110 |
Destruction of skin growth, 1-14 growths | 106 | 92 | $118 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 88 | 74 | $130 | |
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 87 | 60 | $37 | |
11102 |
Biopsy of related skin growth, first growth | 82 | 75 | $87 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 59 | 59 | $111 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | 11 | $1 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 25 | 25 | $170 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 147. This provider delivers 7.9× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
520
Patients
319
Total drug cost
$14,603
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 85 | 69 | $1,160 |
| Hydrocortisone | Generic | 76 | 54 | $673 |
| Clobetasol Propionate | Generic | 68 | 44 | $2,969 |
| Fluocinonide | Generic | 51 | 38 | $2,725 |
| Minoxidil | Generic | 31 | 14 | $424 |
| Hydroxychloroquine Sulfate | Generic | 28 | 0 | $1,354 |
| Ciclopirox | Generic | 27 | 12 | $577 |
| Betamethasone Dipropionate | Generic | 25 | 13 | $1,183 |
| Ketoconazole | Generic | 24 | 14 | $727 |
| Doxycycline Monohydrate | Generic | 23 | 14 | $654 |
Frequently asked questions
What is Dr. Mary Clare Bohnett's medical specialty?
Dr. Mary Clare Bohnett practices Dermatology Physician in Clackamas, OR.
Where does Dr. Mary Clare Bohnett practice?
Dr. Mary Clare Bohnett practices at 10151 Se Sunnyside RD Ste 240, Clackamas, OR 970155774. Office phone: 5039621840.
What is Dr. Mary Clare Bohnett's NPI?
Dr. Mary Clare Bohnett's National Provider Identifier (NPI) is 1710482013, issued by NPPES.
Does Dr. Mary Clare Bohnett accept Medicare assignment?
Yes. Dr. Mary Clare Bohnett accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mary Clare Bohnett commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.